Literature DB >> 23222481

Identifying people at a high risk of developing pancreatic cancer.

Alison P Klein1.   

Abstract

Pancreatic cancer is a leading cause of cancer death, and it has the poorest prognosis of any major tumour type. Familial pancreatic cancer registries are important for investigating the genetic aetiology of this devastating disease. Using data from our familial pancreatic cancer registry and other registries, this Review discusses the usefulness of family registries in the study of pancreatic and other cancers, and also how such registries provide a unique opportunity for laboratory, population and clinical research.

Entities:  

Mesh:

Year:  2012        PMID: 23222481      PMCID: PMC3649844          DOI: 10.1038/nrc3420

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  72 in total

1.  Familial risk of pancreatic cancer.

Authors:  M Schenk; A G Schwartz; E O'Neal; M Kinnard; J K Greenson; J P Fryzek; G S Ying; D H Garabrant
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 13.506

2.  Familial pancreatic cancer in south Louisiana.

Authors:  T F Price; R L Payne; M G Oberleitner
Journal:  Cancer Nurs       Date:  1996-08       Impact factor: 2.592

Review 3.  Familial pancreatic cancer.

Authors:  A P Klein; R H Hruban; K A Brune; G M Petersen; M Goggins
Journal:  Cancer J       Date:  2001 Jul-Aug       Impact factor: 3.360

4.  Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Authors:  Maria C Villarroel; N V Rajeshkumar; Ignacio Garrido-Laguna; Ana De Jesus-Acosta; Siân Jones; Anirban Maitra; Ralph H Hruban; James R Eshleman; Alison Klein; Daniel Laheru; Ross Donehower; Manuel Hidalgo
Journal:  Mol Cancer Ther       Date:  2010-12-06       Impact factor: 6.261

5.  History and molecular genetics of Lynch syndrome in family G: a century later.

Authors:  Julie A Douglas; Stephen B Gruber; Karen A Meister; Joseph Bonner; Patrice Watson; Anne J Krush; Henry T Lynch
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

6.  PALB2 mutations in European familial pancreatic cancer families.

Authors:  E P Slater; P Langer; E Niemczyk; K Strauch; J Butler; N Habbe; J P Neoptolemos; W Greenhalf; D K Bartsch
Journal:  Clin Genet       Date:  2010-11       Impact factor: 4.438

7.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

8.  Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada.

Authors:  P Ghadirian; P Boyle; A Simard; J Baillargeon; P Maisonneuve; C Perret
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

9.  Risk of pancreatic cancer in families with Lynch syndrome.

Authors:  Fay Kastrinos; Bhramar Mukherjee; Nabihah Tayob; Fei Wang; Jennifer Sparr; Victoria M Raymond; Prathap Bandipalliam; Elena M Stoffel; Stephen B Gruber; Sapna Syngal
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

10.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  57 in total

1.  The clinical utility of image-guided iodine-125 seed in patients with unresectable pancreatic cancer.

Authors:  Hongxin Niu; Xikun Zhang; Bin Wang; Zhao Zhou; Jian Wang; Zhongfa Xu
Journal:  Tumour Biol       Date:  2015-09-10

2.  Notch Signaling Pathway in Pancreatic Cancer Progression.

Authors:  Jia Ma; Jun Xia; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2013-05-30

Review 3.  Pancreatic cancer.

Authors:  C Güngör; B T Hofmann; G Wolters-Eisfeld; M Bockhorn
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 4.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

5.  Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.

Authors:  A L Smith; C Bascuñana; A Hall; A Salman; A Z Andrei; A Volenik; H Rothenmund; D Ferland; D Lamoussenery; A S Kamath; R Amre; D Caglar; Z H Gao; D G Haegert; Y Kanber; R P Michel; G Omeroglu-Altinel; J Asselah; N Bouganim; P Kavan; G Arena; J Barkun; P Chaudhury; S Gallinger; W D Foulkes; A Omeroglu; P Metrakos; G Zogopoulos
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

Review 6.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

7.  Increased Incidence of Second Primary Pancreatic Cancer in Patients with Prior Colorectal Cancer: A Population-Based US Study.

Authors:  Erik Rahimi; Sachin Batra; Nirav Thosani; Harminder Singh; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

8.  An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses.

Authors:  Neil Vasan; Maria Ignez Braghiroli; Alexander N Shoushtari; Richard Kinh Gian Do; Marcia Edelweiss; Ali Shamseddine; Walid Faraj; Deborah Mukherji; Ali Haydar; Ashwaq Olayan; Fouad Sabatin; Rita Assi; Imane El Dika; Leonard B Saltz; Ghassan K Abou-Alfa; Eileen M O'Reilly
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 9.  Diagnosis and management of pancreatic cancer.

Authors:  Zaheer S Kanji; Steven Gallinger
Journal:  CMAJ       Date:  2013-04-22       Impact factor: 8.262

10.  Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.

Authors:  Chunling Hu; Steven N Hart; William R Bamlet; Raymond M Moore; Kannabiran Nandakumar; Bruce W Eckloff; Yean K Lee; Gloria M Petersen; Robert R McWilliams; Fergus J Couch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-19       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.